Japan Nicotinamide Phosphoribosyl Transferase Market Research Report 2018

Publisher Name :
Date: 13-Apr-2018
No. of pages: 97
Inquire Before Buying

The global Nicotinamide Phosphoribosyl Transferase market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Nicotinamide Phosphoribosyl Transferase development status and future trend in Japan, focuses on top players in Japan, also splits Nicotinamide Phosphoribosyl Transferase by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Japan market include

- Angelini Group

- Aurigene Discovery Technologies Limited

- Calico LLC

- FORMA Therapeutics, Inc.

- Genentech, Inc.

- Karyopharm Therapeutics, Inc.

- OncoTartis, Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- STF-118804

- P7-C3A20

- KPT-9274

- OT-82

- Others

On the basis of the end users/Application, this report covers

- Research Center

- Hospital

- Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Japan Nicotinamide Phosphoribosyl Transferase Market Research Report 2018

Table of Contents
Japan Nicotinamide Phosphoribosyl Transferase Market Research Report 2018
1 Nicotinamide Phosphoribosyl Transferase Overview
1.1 Product Overview and Scope of Nicotinamide Phosphoribosyl Transferase
1.2 Classification of Nicotinamide Phosphoribosyl Transferase by Product Category
1.2.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Market Share by Type in 2017
1.2.3 STF-118804
1.2.4 P7-C3A20
1.2.5 KPT-9274
1.2.6 OT-82
1.2.7 Others
1.3 Japan Nicotinamide Phosphoribosyl Transferase Market by Application/End Users
1.3.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Japan Revenue and Sales of Nicotinamide Phosphoribosyl Transferase (2013-2025)
1.4.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.4.2 Japan Nicotinamide Phosphoribosyl Transferase Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 Japan Nicotinamide Phosphoribosyl Transferase Market Competition by Players/Manufacturers
2.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Japan Nicotinamide Phosphoribosyl Transferase Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Japan Nicotinamide Phosphoribosyl Transferase Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Japan Nicotinamide Phosphoribosyl Transferase Market Competitive Situation and Trends
2.4.1 Japan Nicotinamide Phosphoribosyl Transferase Market Concentration Rate
2.4.2 Japan Nicotinamide Phosphoribosyl Transferase Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Nicotinamide Phosphoribosyl Transferase Manufacturing Base Distribution, Sales Area, Product Type
3 Japan Nicotinamide Phosphoribosyl Transferase Sales and Revenue (Value) by Type (2013-2018)
3.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Japan Nicotinamide Phosphoribosyl Transferase Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Japan Nicotinamide Phosphoribosyl Transferase Price (USD/Pcs) by Type (2013-2018)
3.4 Japan Nicotinamide Phosphoribosyl Transferase Sales Growth Rate (%) by Type (2013-2018)
4 Japan Nicotinamide Phosphoribosyl Transferase Sales by Application (2013-2018)
4.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Japan Nicotinamide Phosphoribosyl Transferase Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 Japan Nicotinamide Phosphoribosyl Transferase Players/Suppliers Profiles and Sales Data
5.1 Angelini Group
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Angelini Group Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Aurigene Discovery Technologies Limited
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Calico LLC
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Calico LLC Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 FORMA Therapeutics, Inc.
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Genentech, Inc.
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Karyopharm Therapeutics, Inc.
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 OncoTartis, Inc
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Nicotinamide Phosphoribosyl Transferase Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
6 Nicotinamide Phosphoribosyl Transferase Manufacturing Cost Analysis
6.1 Nicotinamide Phosphoribosyl Transferase Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nicotinamide Phosphoribosyl Transferase
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Nicotinamide Phosphoribosyl Transferase Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nicotinamide Phosphoribosyl Transferase Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 Japan Nicotinamide Phosphoribosyl Transferase Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure Japan Market Size (Million USD) Status and Outlook (2013-2025)
Table Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Nicotinamide Phosphoribosyl Transferase
Table Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Volume Market Share by Type in 2017
Figure STF-118804 Product Picture
Figure P7-C3A20 Product Picture
Figure KPT-9274 Product Picture
Figure OT-82 Product Picture
Figure Others Product Picture
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Comparison by Application (2013-2025)
Figure Japan Sales Market Share (%) of Nicotinamide Phosphoribosyl Transferase by Application in 2017
Figure Research Center Examples
Figure Hospital Examples
Figure Clinic Examples
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Japan Nicotinamide Phosphoribosyl Transferase Sales of Key Players/Manufacturers (2013-2018)
Table Japan Nicotinamide Phosphoribosyl Transferase Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Nicotinamide Phosphoribosyl Transferase Sales Share (%) by Players/Manufacturers
Figure 2017 Japan Nicotinamide Phosphoribosyl Transferase Sales Share (%) by Players/Manufacturers
Table Japan Nicotinamide Phosphoribosyl Transferase Revenue by Players/Manufacturers (2013-2018)
Table Japan Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Nicotinamide Phosphoribosyl Transferase Revenue Share (%) by Players/Manufacturers
Figure 2017 Japan Nicotinamide Phosphoribosyl Transferase Revenue Share (%) by Players/Manufacturers
Table Japan Market Nicotinamide Phosphoribosyl Transferase Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Japan Market Nicotinamide Phosphoribosyl Transferase Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Japan Nicotinamide Phosphoribosyl Transferase Market Share of Top 3 Players/Manufacturers
Figure Japan Nicotinamide Phosphoribosyl Transferase Market Share of Top 5 Players/Manufacturers
Table Japan Players/Manufacturers Nicotinamide Phosphoribosyl Transferase Manufacturing Base Distribution and Sales Area
Table Japan Players/Manufacturers Nicotinamide Phosphoribosyl Transferase Product Category
Table Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) by Type (2013-2018)
Table Japan Nicotinamide Phosphoribosyl Transferase Sales Share (%) by Type (2013-2018)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Share (%) by Type (2013-2018)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) by Type in 2017
Table Japan Nicotinamide Phosphoribosyl Transferase Revenue (Million USD) and Market Share by Type (2013-2018)
Table Japan Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Nicotinamide Phosphoribosyl Transferase by Type (2013-2018)
Figure Revenue Market Share of Nicotinamide Phosphoribosyl Transferase by Type in 2017
Table Japan Nicotinamide Phosphoribosyl Transferase Price (USD/Pcs) by Type (2013-2018)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Growth Rate (%) by Type (2013-2018)
Table Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) by Application (2013-2018)
Table Japan Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) by Application (2013-2018)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) by Application (2013-2018)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) by Application in 2017
Table Japan Nicotinamide Phosphoribosyl Transferase Sales Growth Rate (%) by Application (2013-2018)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Growth Rate (%) by Application (2013-2018)
Table Angelini Group Nicotinamide Phosphoribosyl Transferase Basic Information List
Table Angelini Group Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Angelini Group Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Angelini Group Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure Angelini Group Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Basic Information List
Table Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table Calico LLC Nicotinamide Phosphoribosyl Transferase Basic Information List
Table Calico LLC Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Calico LLC Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Calico LLC Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure Calico LLC Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Basic Information List
Table FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Basic Information List
Table Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Basic Information List
Table Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Basic Information List
Table OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Sales Market Share (%) in Japan (2013-2018)
Figure OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Revenue Market Share (%) in Japan (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nicotinamide Phosphoribosyl Transferase
Figure Manufacturing Process Analysis of Nicotinamide Phosphoribosyl Transferase
Figure Nicotinamide Phosphoribosyl Transferase Industrial Chain Analysis
Table Raw Materials Sources of Nicotinamide Phosphoribosyl Transferase Major Players/Manufacturers in 2017
Table Major Buyers of Nicotinamide Phosphoribosyl Transferase
Table Distributors/Traders List
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Price (USD/Pcs) Trend Forecast (2018-2025)
Table Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Forecast by Type (2018-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Forecast by Type (2018-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Volume Market Share Forecast by Type in 2025
Table Japan Nicotinamide Phosphoribosyl Transferase Sales (K Pcs) Forecast by Application (2018-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Volume Market Share Forecast by Application (2018-2025)
Figure Japan Nicotinamide Phosphoribosyl Transferase Sales Volume Market Share Forecast by Application in 2025
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs